Shuang Cui

机构：FIND, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, China Academy of Chinese Medical Sciences · ORCID：0000-0002-0859-3141

发表论文 50 篇 · 总被引 1740 次 · h-index 22

代表论文

• SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis (2020 · Nature Communications · 被引 144)
• Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis (2018 · Acta Pharmaceutica Sinica B · 被引 105)
• Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis (2018 · EBioMedicine · 被引 53)
• A nociceptive neuronal ensemble in the dorsomedial prefrontal cortex underlies pain chronicity (2022 · Cell Reports · 被引 47)
• EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2 (2021 · Cell Death and Disease · 被引 40)
• SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR (2022 · Acta Pharmaceutica Sinica B · 被引 35)